DelSite Biotechnologies, Inc.
1505 Walnut Hill Lane
Irving
Texas
75038
United States
Tel: 972-717-5009 Or 800-358-5213<br>
Fax: 972-871-1132
Website: http://www.delsite.com/
Email: lmurray@delsitebiotech.com
57 articles about DelSite Biotechnologies, Inc.
-
DelSite Biotechnologies, Inc. Announces Intention to License Manapol(R) Manufacturing Rights, Fields of Use and Territories
2/18/2009
-
DelSite Biotechnologies, Inc.. Discontinues Manufacturing Operations; Receives FDA Approval to Initiate Phase I Clinical Study for GelVac(TM) Nasal Powder Bird Flu Vaccine
1/26/2009
-
DelSite Biotechnologies, Inc. Chairman George DeMott Resigns
12/11/2008
-
DelSite Biotechnologies, Inc. Reports Third Quarter 2008 Results
11/13/2008
-
DelSite Biotechnologies, Inc. Presents Nasal Powder and Synthetic Typhoid Vaccine Technologies at the 2nd Vaccines Asia Conference
11/13/2008
-
DelSite Biotechnologies, Inc. Patent for GelSite(R) Polymer Technology Issued
11/12/2008
-
DelSite Biotechnologies, Inc. Announces Third Quarter 2008 Earnings Conference Call
11/11/2008
-
DelSite Biotechnologies, Inc. Files IND for Nasal Powder H5N1 (Bird Flu) Influenza Vaccine
8/20/2008
-
DelSite Biotechnologies, Inc. Nasal Powder Vaccine Platform Highlighted At Cambridge Healthtech Institute
8/18/2008
-
DelSite Biotechnologies, Inc. Reports Second Quarter 2008 Results
8/14/2008
-
DelSite Biotechnologies, Inc. Announces Second Quarter 2008 Earnings Conference Call
8/12/2008
-
DelSite Biotechnologies, Inc. Subsidiary Sabila Industrial in Costa Rica Completes ISO 9001:2000 Inspection
8/4/2008
-
DelSite Biotechnologies, Inc.'s New Stock Symbol is DSII.OB
7/31/2008
-
DelSite Biotechnologies, Inc. Sells Wound Care Division to Medline Industries, Inc.
7/31/2008
-
DelSite Biotechnologies, Inc. Advances Nasal Delivery of Therapeutic Peptide
7/15/2008
-
Carrington Laboratories, Inc. Changes Its Name to DelSite Biotechnologies, Inc.
7/8/2008
-
DelSite Biotechnologies, Inc. Announces Development of Unique Synthetic Typhoid Vi Polysaccharide Vaccine Candidate
6/26/2008
-
Carrington Laboratories, Inc. Subsidiary DelSite Biotechnologies, Inc. Extends Commercial Evaluation License Agreement With National Institutes of Health (NIH) for Typhoid Vaccine
5/16/2008
-
DelSite Biotechnologies, Inc. Signs Technology Evaluation Agreement With Global Pharmaceutical Company for GelSite(R) Polymer
4/16/2008
-
ImmuneRegen BioSciences, Inc. and DelSite Biotechnologies, Inc. Collaborate on New Flu Treatment
3/24/2008